GlassScriptPhysician profile
Alexander Miller
NPI 1932779840
$2,401.10
in general payments reported to CMS, 2019-2025
13 companies · $810 in 2025
The $810 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $635 · 2023: $491 · 2024: $465 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,765.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $645.06 | 2022-2025 | |
| Apellis Pharmaceuticals, INC. | $376.18 | 2024-2025 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $367.38 | 2022-2025 | Eylea Hd |
| Alcon Vision LLC | $300.40 | 2022-2023 | Rocklatan |
| Glaukos Corporation | $145.63 | 2024 | Idose |
| Bausch & Lomb Americas INC. | $130.82 | 2022 | |
| Genentech USA, INC. | $125.42 | 2022-2025 | Vabysmo |
| Neurotech Pharmaceuticals, INC. | $85.96 | 2025 | |
| Dutch Ophthalmic, USA | $69.07 | 2025 | Eva, Combined Machine, Tissueblue |
| Sight Sciences, INC. | $65.13 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Regeneron Pharmaceuticals, INC. | $44.57 | 2025 | Eylea Hd |
| Boston Scientific Corporation | $24.98 | 2023 | |
| Ani Pharmaceuticals, INC. | $20.50 | 2025 | Iluvien |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.